Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Ben Price purchased 5,000,000 shares of the business’s stock in a transaction on Monday, March 31st. The stock was purchased at an average cost of A$0.01 ($0.01) per share, for a total transaction of A$60,000.00 ($37,974.68).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Read More
- Five stocks we like better than Percheron Therapeutics
- When to Sell a Stock for Profit or Loss
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- The How And Why of Investing in Oil Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Investing in Construction Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
